E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe
ConditionCancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age12+
SponsorEuropean Organisation for Research and Treatment of Cancer - EORTC
About this trial
The primary objective is the collection of real-world data of cancer patients treated with radiotherapy, to support radiotherapy research and to provide evidence of the role of radiation oncology in a multidisciplinary approach. This is an open ended prospective non-interventional non-therapeutic multi-cohort study.
Eligibility criteria
Qualifiers
Pathologically confirmed cancer.
Written informed consent for E²-RADIatE according to applicable legal and ethical requirements
Planned use of radiotherapy
Eligibility of the patient confirmed for at least one cohort confirmed
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
2,000 Participants
are grouped into 2 trial groupsSponsors and collaborators
Source ClinicalTrials.gov